Journal Home
Search for

Volume 51, Issue 3, Pages 385-394 (March 2008)


View previous. 16 of 38 View next.

Serum Cystatin C in the United States: The Third National Health and Nutrition Examination Survey (NHANES III)

Anna Köttgen, MD, MPH1, Elizabeth Selvin, PhD, MPH1, Lesley A. Stevens, MD, MS2, Andrew S. Levey, MD2, Frederick Van Lente, PhD3, Josef Coresh, MD, PhD145Corresponding Author Informationemail address

Received 2 September 2007; accepted 17 November 2007.

Refers to article:
Cystatin C: Research Priorities Targeted to Clinical Decision Making
Michael G. Shlipak
American Journal of Kidney Diseases
March 2008 (Vol. 51, Issue 3, Pages 358-361)
Full Text | Full-Text PDF (70 KB)
Background

Serum cystatin C increasingly is used as a marker of glomerular filtration rate and cardiovascular risk. However, information for serum cystatin C levels in the general population, specifically across a wide age range and different ethnicities, is lacking.

Objectives

To determine nationally representative serum cystatin C levels, estimate the prevalence of increased cystatin C levels in the general population, and identify factors associated with increased cystatin C levels.

Study Design

Cross-sectional survey.

Setting and Participants

A nationally representative subsample of 7,596 participants aged 12 years or older in the Third National Health and Nutrition Examination Survey conducted in 1988-1994.

Predictors

Age, sex, race/ethnicity, risk factors for chronic kidney disease.

Outcomes

Continuous serum cystatin C levels and serum cystatin C level greater than 1.12 mg/L.

Measurements

Cystatin C was measured in 2006 from stored sera by using an automated particle-enhanced nephelometric assay.

Results

Overall median serum cystatin C level was 0.85 mg/L. Median cystatin C levels increased steeply with age and were greater in males and non-Hispanic white persons, even in a healthy subgroup of 20- to 39-year-olds. Prevalences of increased serum cystatin C levels (>1.12 mg/L) were 1%, 41%, and greater than 50% in all persons aged younger than 20 years, 60 years or older, and 80 years or older. In persons aged 60 years and older, older age, non-Hispanic white ethnicity, hypertension, current smoking, lower levels of education and high-density lipoprotein cholesterol, and increased body mass index, C-reactive protein, and triglyceride values were associated significantly with increased serum cystatin C levels.

Limitations

No measured glomerular filtration rate, single measurement of cystatin C, cross-sectional study design.

Conclusions

Serum cystatin C level is related to sex and ethnicity, even in young healthy individuals. The prevalence of increased cystatin C levels increases dramatically with age, reaching greater than 50% after the age of 80 years in both sexes and all ethnic groups.

1 Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health and the Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institutions, Baltimore, MD

2 Division of Nephrology, Tufts-New England Medical Center, Boston, MA

3 Department of Clinical Pathology, Cleveland Clinic Foundation, Cleveland, OH

4 Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health and Johns Hopkins Hospital, Baltimore, MD

5 Department of Medicine, Johns Hopkins Bloomberg School of Public Health and Johns Hopkins Hospital, Baltimore, MD.

Corresponding Author InformationAddress correspondence to Josef Coresh, MD, PhD, Welch Center for Prevention, Epidemiology & Clinical Research, 2024 E Monument St, Baltimore, MD 21287.

 Because an author of this manuscript is an editor for AJKD, the peer-review and decision-making processes were handled entirely by an Associate Editor (Marcello Tonelli, MD, University of Alberta) who served as Acting Editor-in-Chief. Details of the journal’s procedures for potential editor conflicts are given in the Editorial Policies section of the AJKD website.

PII: S0272-6386(07)01595-8

doi:10.1053/j.ajkd.2007.11.019


View previous. 16 of 38 View next.